A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss
NCT00108524 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 146
Last updated 2014-04-17
Summary
This study compares two types of diet interventions: a low carbohydrate ketogenic diet (Atkins) and a low-fat diet combined with a medication (Orlistat).
Conditions
Interventions
- BEHAVIORAL
-
Low carbohydrate ketogenic diet
A low-carb diet limits carbohydrates - such as grains, starchy vegetables and fruit - and emphasizes dietary protein and fat.
- DRUG
-
Orlistat
In addition to the low fat diet, Orlistat is taken 3 times daily.
- BEHAVIORAL
-
Low-fat diet
Participants receive counseling on a low fat diet over 48 weeks aimed at reducing fat and calorie intake
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Principal Investigators
-
William S. Yancy, MD MHS · Durham VA Medical Center HSR&D COE
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 69 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-07-31
- Primary Completion
- 2007-12-31
- Completion
- 2007-12-31
Countries
- United States
Study Locations
More Related Trials
-
A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)
NCT00092872 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)
NCT00533481 ·Status: COMPLETED ·Phase: PHASE2
-
Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
NCT03041792 ·Status: COMPLETED ·Phase: PHASE1
-
Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.
NCT03856047 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity
NCT03479892 ·Status: COMPLETED ·Phase: PHASE1
-
Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
NCT03661879 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effect of 7-Keto on Resting Metabolic Rate in Overweight Adults
NCT04782024 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight
NCT06824051 ·Status: COMPLETED ·Phase: PHASE1
-
Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat
NCT00991926 ·Status: COMPLETED
-
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
NCT07232719 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance
NCT00781937 ·Status: COMPLETED ·Phase: PHASE3
-
RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.
NCT07301437 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity
NCT06859268 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients
NCT00483171 ·Status: TERMINATED ·Phase: PHASE3
-
A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese
NCT03574584 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus
NCT02453711 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
NCT02870231 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms
NCT01550926 ·Status: COMPLETED ·Phase: PHASE1
-
Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin
NCT02963922 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss
NCT07280403 ·Status: COMPLETED ·Phase: NA
-
An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)
NCT00109148 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
NCT07184632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group
NCT01511185 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects
NCT01719419 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes
NCT01511692 ·Status: COMPLETED ·Phase: PHASE1